biomodal is thrilled to be heading to AGBT 2026!
We can’t wait to connect with the innovators, trailblazers, and visionaries shaping the future of genomics. Our team will be onsite sharing how biomodal’s pioneering multiomic technology unlocks the complete 6‑base genome, giving researchers unparalleled clarity into epigenetic complexity. Craig Fishman, Head of Sales Americas Region, will be attending and is eager to meet with you. If you’re ready to explore how biomodal can elevate your research, book time with Craig at AGBT.
The General Meeting is AGBT’s flagship event for bringing together global leaders, researchers, and innovators.
Advances in Genome Biology and Technology (AGBT) delivers a premier experience where heads of labs, institutions, businesses, financial analysts and other high-level stakeholders come together to advance the field and drive game-changing innovation. Significant scientific advances are announced and showcased, science and industry forge enduring partnerships, and significant investments and notable acquisitions are made.
